Navigation Links
DrugRisk Adds Latest Health Warnings and Lawsuit Updates for Yaz
Date:1/5/2013

New York, NY (PRWEB) January 05, 2013

The prescription drug resource center DrugRisk.com has updated its comprehensive database to include the latest warnings on Yaz side effects as well as legal news on the ongoing Yaz litigation and settlements.

“The goal of DrugRisk is to improve patient safety through education. This includes furnishing the latest warnings, recalls, studies and litigation news related to prescription drugs like Yaz and Yasmin used by millions of women,” explains DrugRisk representative Ryan Mayer.

The resource center is advising patients of the latest Yaz health warning, in which the American College of Obstetricians and Gynecologists cautioned that birth control pills containing drospirenone, such as Yaz and Yasmin, may have a higher risk of causing blood clots.*

DrugRisk also contains studies previously issued by the British Medical Journal and U.S. Food and Drug Administration which show drugs like Yaz can increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%.**

In legal news, DrugRisk has learned that thousands of Yaz lawsuits have been consolidated to a special federal Multi-District Litigation court in Illinois. The formal case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois).

According to the most recent financial report from Bayer, the company has settled approximately 3,500 of these Yaz claims, at a total cost of nearly $750 million, or around $214,000 per case.*** Bayer also confirmed they are only settling claims involving blood clot injuries, such as deep vein thrombosis and pulmonary embolism.

Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Drug Risk Resource Center or speak with a lawyer about their legal options.

The Drug Risk Resource Center cautions victims who wish to learn about their legal options that they should seek a lawyer with experience in defective drug litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.

For more information on the research, side effects and litigation news related to Yaz and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*Chicago Tribune October 24, 2012, “Newer Pill has low blood clot risk: ob-gyn group”
**British Medical Journal, October 25, 2011, University of Copenhagen; FDA, October 27, 2011, "Combined Hormonal Contraceptives and the Risk of Cardiovascular Disease Endpoints"
***Bayer Interim Financial Statement, Legal Notes and Business Development, September 30, 2012

Read the full story at http://www.prweb.com/releases/yaz-lawsuits/claims/prweb10290083.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DrugRisk Announces Updated Information on Mirena Lawsuits
2. DrugRisk Announces Alternative to Mirena IUD May Be Available Soon
3. DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
4. Nutrisystem Announces Latest Weight Loss Success Story: Long Beach Husband and Wife Drop a Combined Total of 46 Pounds; Plus, Expert Dieting Tips for Couples
5. Greg Reid of Napoleon Hill Foundation Makes a Special World Premier Announcement of His Latest Project (The Secret of Happiness) on the “Your Do Over” Podcast on iTunes
6. Nutrisystem Announces Latest Weight Loss Success Story: Life-long Fad Dieter Shari West Finds the Key to Dropping Nearly 60 Pounds*
7. Vitamin D & Your Health Report Latest Release from MedSmart Members
8. Dr. Ilan Cohen Advises Caution with Latest Flurry of “No Cost” LASIK Screening Offers
9. Atlanta Plastic Surgeon Dr. David Whiteman Says Increased Popularity of Ethnic Rhinoplasty, Indicated by Latest ASPS Statistics, Emphasizes Need for Experienced Surgeons
10. Cavern Technologies Kansas City Data Center Continues Rapid Growth with Latest Data Center Expansion
11. Latest West Nile Tally: 5,245 Cases, 236 Deaths
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2017)... , ... May 22, 2017 , ... Galena, Alaska, has ... Arctic Circle made big headlines when it was targeted to build a nuclear plant ... Bush Alaska,” former city manager Marvin L. Yoder describes the journey to get power ...
(Date:5/22/2017)... ... May 22, 2017 , ... ... on Wellocity to empower WeightZone Factor members to track their exercise patterns, monitor ... excellent health education, all on their mobile phones. It also provides social networks ...
(Date:5/21/2017)... , ... May 19, 2017 , ... Chris Cornell, 52, was found dead on the ... one of the most respected lead singers in the rock industry would take his own ... mental illness. FindaTopDoc investigates how mental illness played a role in the death of ...
(Date:5/21/2017)... ... May 20, 2017 , ... ... between ABC Financial Services and financial systems. , Dozens of clubs ... files that are electronically processed through GetLinked into their club’s accounting system , ...
(Date:5/21/2017)... ... 20, 2017 , ... Pot. Reefer. Grass. Mary Jane. No matter what people ... attributes like never before. More than a map, new social marketplace Weedable ... products – and for the first time – each other. A social marketplace like ...
Breaking Medicine News(10 mins):
(Date:5/18/2017)... , May 18, 2017  Two Bayer U.S. ... Association (HBA) during its recent 28 th ... City.  The event showcases HBA,s longstanding mission of furthering ... of healthcare. Cindy Powell-Steffen , senior ... U.S. Radiology division, and Libby Howe , a ...
(Date:5/15/2017)... PHILADELPHIA , May 15, 2017 Enterin Inc., ... and developing novel compounds to treat Parkinson,s disease ... The study is a Phase 1/2a randomized, controlled, multicenter study ... sites. It will enroll 50 patients over a 9-to-12-month period. ... doses in 10 patients with PD. Participating sites include ...
(Date:5/10/2017)... May 10, 2017 Hologic, Inc. (Nasdaq: ... for the fiscal second quarter ended April 1, 2017 ... $1.84 increased 666.7% compared to the prior year period ... in a significant gain, while non-GAAP diluted EPS of ... or 3.8% in constant currency terms.  Excluding the effects ...
Breaking Medicine Technology: